Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lipoprotein(a)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03320265
What this trial is testing

Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a

Who this might be right for
Arterial InflammationCardiovascular Diseases
Athera Biotechnologies AB 10
Early research (Phase 1)Looking for participantsNCT06980428
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

Who this might be right for
Healthy ParticipantsDyslipidemia
AstraZeneca 136
Not applicableStudy completedNCT06595069
What this trial is testing

A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients

Who this might be right for
Hypercholesterolemia
Novartis 600
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Early research (Phase 1)Looking for participantsNCT07626281
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

Who this might be right for
Inclisiran Formulation
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT05079919
What this trial is testing

Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 617
Not applicableWithdrawnNCT04993664
What this trial is testing

Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)

Who this might be right for
Acute Coronary SyndromeLipoproteinemiaInflammation+1 more
University Medical Centre Ljubljana
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Large-scale testing (Phase 3)Ended earlyNCT01294683
What this trial is testing

Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)

Who this might be right for
Primary HypercholesterolemiaDyslipidemia
Merck Sharp & Dohme LLC 977
Not applicableLooking for participantsNCT07577609
What this trial is testing

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

Who this might be right for
Coronary Artery Disease (CAD)Computed Tomography AngiographyBiomarkers+4 more
University of Galway 10,000
Not applicableStudy completedNCT01333436
What this trial is testing

Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

Who this might be right for
DyslipidemiaHypercholesterolemia
Organon and Co 93
Not applicableStudy completedNCT00535886
What this trial is testing

The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study

Who this might be right for
Cardiovascular DiseaseDiabetesDyslipidemia
UCSF Benioff Children's Hospital Oakland 15
Large-scale testing (Phase 3)Study completedNCT00028301
What this trial is testing

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT06692764
What this trial is testing

Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Who this might be right for
Atherosclerotic Cardiovascular Disease
AstraZeneca 202
Post-approval studies (Phase 4)Study completedNCT00645151
What this trial is testing

The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Early research (Phase 1)Study completedNCT03392051
What this trial is testing

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Who this might be right for
Elevated Lipoprotein(a)Cardiovascular Diseases
Akcea Therapeutics 18
Large-scale testing (Phase 3)Looking for participantsNCT07136012
What this trial is testing

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Who this might be right for
Cardiovascular Disease
Amgen 11,000
Testing effectiveness (Phase 2)Looking for participantsNCT07368608
What this trial is testing

BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）

Who this might be right for
Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol
BeBetter Med Inc 340
Early research (Phase 1)Study completedNCT01959971
What this trial is testing

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

Who this might be right for
Hypercholesterolemia
Sanofi 20
Not applicableStudy completedNCT04841915
What this trial is testing

Dairy Protien Rich Diet for NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMetabolic SyndromeCaseins+4 more
University of Aarhus 46
Next Page